Cargando…
Integrase inhibitors: Why do we need a new drug class for HIV therapy?
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3516821/ https://www.ncbi.nlm.nih.gov/pubmed/19959410 http://dx.doi.org/10.1186/2047-783X-14-S3-1 |
_version_ | 1782252347226849280 |
---|---|
author | Rockstroh, Jürgen Kurt |
author_facet | Rockstroh, Jürgen Kurt |
author_sort | Rockstroh, Jürgen Kurt |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-3516821 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-35168212012-12-11 Integrase inhibitors: Why do we need a new drug class for HIV therapy? Rockstroh, Jürgen Kurt Eur J Med Res Review BioMed Central 2009-11-24 /pmc/articles/PMC3516821/ /pubmed/19959410 http://dx.doi.org/10.1186/2047-783X-14-S3-1 Text en Copyright ©2009 I. Holzapfel Publishers |
spellingShingle | Review Rockstroh, Jürgen Kurt Integrase inhibitors: Why do we need a new drug class for HIV therapy? |
title | Integrase inhibitors: Why do we need a new drug class for HIV therapy? |
title_full | Integrase inhibitors: Why do we need a new drug class for HIV therapy? |
title_fullStr | Integrase inhibitors: Why do we need a new drug class for HIV therapy? |
title_full_unstemmed | Integrase inhibitors: Why do we need a new drug class for HIV therapy? |
title_short | Integrase inhibitors: Why do we need a new drug class for HIV therapy? |
title_sort | integrase inhibitors: why do we need a new drug class for hiv therapy? |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3516821/ https://www.ncbi.nlm.nih.gov/pubmed/19959410 http://dx.doi.org/10.1186/2047-783X-14-S3-1 |
work_keys_str_mv | AT rockstrohjurgenkurt integraseinhibitorswhydoweneedanewdrugclassforhivtherapy |